Medindia

X

Cardio Vascular Medical Device Announces Plans on Listing on a European Exchange

Friday, December 4, 2009 General News J E 4
Advertisement
HAIFA, Israel, December 3 Cardio Vascular Medical DeviceCorp. (CVSL.OB), a leading developer of advanced cardiovascular surgerytechnology, today announced that the Company is considering a listing on aEuropean exchange due to growing demand from foreign investors and to furthercoordinate marketing efforts in Europe. The Company is now in discussionswith various exchanges to determine the best alternative for its shareholders.

"Listing our company on an exchange in Europe will help to grow ourshareholder base and better enable us to seek capital as well as marketingopportunities abroad," stated Eli Gonen, CEO of Cardio Vascular MedicalDevice Corp. "We have already received great interest from various parties inEurope for our patented guidewire, and are confident that our proprietarytechnology can aid in the performance of angioplasty procedures in developedcountries across the world."

About Cardio Vascular Medical Device

Cardio Vascular Medical Device holds a US patent for an innovativenext-generation "steerable guidewire" applicable for all angioplasty (PCTA)procedures. The technology hinges on a bendable tip that improves guidewireperformance, enables faster procedure completion, and provides cost benefitsfor patients as well as healthcare providers. The guidewire has a uniqueopportunity to become the guidewire of choice for surgeons throughout theworld.

Learn more about Cardio Vascular Medical Device at:http://www.cvslmedical.com

Forward-Looking Statements

This letter contains forward-looking statements within the meaning ofSection 27A of the Securities Act of 1933, as amended and Section 21E of theSecurities Exchange Act of 1934, as amended. All forward-looking statementsare inherently uncertain, based on current expectations and assumptionsconcerning future events or future performance of Cardio Vascular MedicalDevice Corp. and its technologies. In evaluating such statements, prospectiveinvestors should review carefully various risks and uncertainties identifiedin this release, as actual results may differ materially from those indicatedin the forward-looking statements. Cardio Vascular Medical Device Corp.public filings may be viewed at http://www.sec.gov.Contact: Alex Traiman Media Relations +1-646-863-9729 Asher Zwebner +972-54-464-6363 asher@fxmng.com

SOURCE Cardio Vascular Medicine Device Corp.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Health Care Increases Stress and Decreases Spendin...
S
Pioneer(R) Surgical Technology, Inc. Receives Pres...